Global Pharmaceutical Grade Lactose Market is Estimated to Reach USD 395 Mn by 2031; states TNR

November 29, 2023 02:10 PM CET | By EIN Presswire
Follow us on Google News:

Rise in Demand for Customized Lactose Formulations by Pharmaceutical Companies is Driving the Global Pharmaceutical Grade Lactose Market

WILMINGTON, DELAWARE, UNITED STATES, November 29, 2023 / -- Pharmaceutical grade lactose is a high-quality form of lactose that meets stringent purity and quality standards required for pharmaceutical and medical applications. Lactose is a sugar found in milk and is commonly used as a pharmaceutical excipient, which is a substance added to a medication or drug formulation to improve its physical properties, stability, or other characteristics.

Get Sample Copy of the Report

The use of lactose in pharmaceuticals has seen a rise in recent years due to several factors, including its versatility and suitability for various drug delivery systems and formulations. As lactose is commonly used as a filler or diluent in the production of solid dosage forms such as tablets and capsules. Its ability to provide uniform distribution of active ingredients and its compatibility with a wide range of drugs make it a preferred choice. Besides in the last few years, pharmaceutical companies are increasingly developing patient-centric formulations that are easier to take and more convenient. Lactose plays a role in achieving these goals, especially in the development of user-friendly dosage forms which has led to its increased demand and overall growth of the global pharmaceutical grade lactose market.

Global Pharmaceutical Grade Lactose Market Snapshot

Market Value in 2022 : USD 223 Million
Market Value Forecast 2031: USD 395 Million
Growth Rate: 5.7%
Historical Data : 2015-2021
Base Year : 2022
Forecast Data : 2023-2031

Speak to our analyst in case of queries before buying this report

Global Pharmaceutical Grade Lactose Market Type Insights
In 2022, α-lactose monohydrate had the highest share in the pharmaceutical grade lactose market. Lactose grades with varying physical features, such as particle size distribution and flow characteristics, are commercially available. Crystalline α-lactose monohydrate is the most frequent type of lactose used in pharmaceutical manufacturing. This form comes in a variety of milled and sifted pharmaceutical grades with varying physical qualities such as flowability, bulk density, and particle size distribution. Moreover it is commonly employed as a filler, binder, or diluent in the production of solid dosage forms, such as tablets and capsules. Lactose monohydrate helps in achieving the desired tablet hardness and disintegration properties which has led to the rise in demand.
On the other hand other lactose variants, such as anhydrous lactose (with all water removed) and lactose hydrates (with varying water content), are also being used in specific formulations where their properties are better suited to the desired characteristics of the drug product.

Global Pharmaceutical Grade Lactose Market Distribution Channel Insights
Based on the distribution channel in the pharmaceutical grade lactose market, direct distribution had the highest share in 2022, as direct distribution allows for better control over the quality and integrity of pharmaceutical grade lactose. Manufacturers can maintain strict quality control standards and ensure that the product meets pharmacopeial and regulatory requirements throughout the distribution process. Besides pharmaceutical grade lactose is subjected to strict regulatory requirements, a direct distribution channel allows manufacturers to ensure that the product is compliant with the necessary standards and regulatory guidelines.

Global Pharmaceutical Grade Lactose Market Regional Insights
Asia Pacific region is anticipated to be the fastest growing region in the pharmaceutical grade lactose market during the forecast period. The adoption of lactose in the pharmaceutical industry in Asia is driven by its cost-effectiveness, versatility, compatibility with APIs, and suitability for various formulations. As the pharmaceutical market in Asia continues to grow, lactose remains a valuable excipient for drug manufacturers in the region as lactose is a versatile excipient that can be used in various pharmaceutical formulations, including tablets, capsules, dry powder inhalers, and orally disintegrating tablets (ODTs). Its adaptability to different drug delivery systems makes it a versatile choice for drug manufacturers. Thus with the flourishing pharmaceutical industry in Asia, the pharmaceutical grade lactose market will experience huge growth in the upcoming years.

Request for customization to meet your precise research requirements

Key Developments in Global Pharmaceutical Grade Lactose Market
• In July 2021, Safic-Alcan, a worldwide specialty chemicals distributor, announced a new partnership with Armour Pharma, a French manufacturer of pharma-grade lactose, covering the United Kingdom. This partnership strengthens Safic-Alcan UK's capacity to deliver a diverse variety of industry-leading solutions to its pharmaceutical sector customers.

Global Pharmaceutical Grade Lactose Market Competitors
o Alpavit
o Armor Pharma
o DFE Pharma
o Fengchen Group Co., Ltd
o FrieslandCampina
o International Ingredients & Excipients Pvt. Ltd.
o Kerry Group plc
o Lactalis Ingredients
o Lactose (India) Limited
o MEGGLE GmbH & Co. KG
o Merck KGaA
o RCI Labscan Limited.
o Surfachem Group Ltd.
o Other Market Participants

Global Pharmaceutical Grade Lactose Market
By Type
o Crystalline
o α-lactose monohydrate
o Anhydrous Lactose (β-lactose)
o Spray Dried Monohydrate
o Lactose hydrous
o Amorphous lactose
By Application
o Direct Compression
o Dry Granulation
o Wet Granulation
o Orally Dispersible Tablet
o Capsules
o Others
By Distribution Channel
o Direct
o Indirect

By Region
o North America (U.S., Canada, Mexico, Rest of North America)
o Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
o Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
o Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
o Latin America (Brazil, Argentina, Rest of Latin America)

Consult with Our Expert:
Jay Reynolds
The Niche Research
Japan (Toll-Free): +81 663-386-8111
South Korea (Toll-Free): +82-808- 703-126
Saudi Arabia (Toll-Free): +966 800-850-1643
United Kingdom: +44 753-710-5080
United States: +1 302-232-5106
Email: [email protected]

Jay Reynolds
The Niche Research
+1 302-232-5106
email us here


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK